Singue, Nera L.
HRN: 23-95-16 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/24/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/24/2023
10/31/2023
IV
2.25gms
Q8
Sepsis
Checking Final Appropriateness